Tissue marker migration after MRI-guided breast biopsy: Migration frequency and associated factors.
MRI breast biopsy
breast MRI
breast imaging
clip migration
Journal
The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
08
02
2019
revised:
05
07
2019
accepted:
09
07
2019
pubmed:
27
8
2019
medline:
22
6
2021
entrez:
27
8
2019
Statut:
ppublish
Résumé
The purpose of this study was to determine the frequency and associated risk factors contributing to immediate tissue marker migration in patients undergoing MRI-guided breast biopsy and to evaluate how often tissue marker migration altered clinical management. Between July 2010 and May 2015, we retrospectively reviewed all MRI-guided breast biopsies at our institution for tissue marker migration. Migration was defined as final position of the tissue marker >10 mm from the target site based on the expected location of the MRI finding on postprocedure mammogram. Factors associated with migration were analyzed using Fisher's exact test and Chi-squared test, with P < .05 considered statistically significant. A total of 278 patients underwent 298 MRI-guided biopsies. Migration occurred in 42/298 biopsies (14%). Almost entirely fat fibroglandular tissue was identified as an independent risk factor for tissue marker migration, occurring in 6/16 (38%), compared to 36/262 (14%) for the other fibroglandular tissue categories (P = .03). Biopsy target size was significantly associated with clip migration, occurring in 25/114 (22%) lesions <10 mm in size vs 17/184 (9%) for larger lesions (P = .003). Clinical management was affected by clip migration in 6/42 cases (14%) with one requiring ultrasound-guided biopsy cavity marker placement and five requiring biopsy cavity wire localization. Radiologists must be vigilant in assessing for clip migration as it is not an infrequent complication. Given migration may change clinical management and require altered procedures for localization of the biopsy cavity, the possibility of clip migration should be included in informed consent.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
440-445Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Thomassin-Naggara I, Lalonde L, David J, Darai E, Uzan S, Trop I. A plea for the biopsy marker: how, why and why not clipping after breast biopsy? Breast Cancer Res Treat. 2012;132:881-893.
Esserman LE, Cura MA, DaCosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics. 2004;24:147-156.
Kass R, Kumar G, Klimberg VSuzanne, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002;184:325-331.
Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology. 2001;218:510-516.
Liberman L, Dershaw DD, Morris EA, Abramson AF, Thornton CM, Rosen PP. Clip placement after stereotactic vacuum-assisted breast biopsy. Radiology. 1997;205(2):417-422.
Chadwick DR, Shorthouse AJ. Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer. Eur J Surg Oncol. 1997;23:128-133.
Le-Petross HT, Hess KR, Knudtson JD, et al. Effect of mammography on marker clip migration after stereotactic-guided core needle breast biopsy. Curr Probl Diagn Radiol. 2017;46:410-414.
Rauch GM, Dogan BE, Smith TB, Liu P, Yang WT. Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol. 2012;198:292-299.
Jain A, Khalid M, Qureshi MM, et al. Stereotactic core needle breast biopsy marker migration: an analysis of factors contributing to immediate marker migration. Eur Radiol. 2017;27:4797-4803.
Causer PA, Piron CA, Jong RA, et al. MR imaging-guided breast localization system with medial or lateral access. Radiology. 2006;240:369-379.
Kaplan J, Grinstaff M, Bloch BN. Polymer film-nano particle composites as new multimodality, non migrating breast biopsy markers. Eur Radiol. 2016;26:866-873.
Harvey JR, Lim Y, Murphy J, et al. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study. Breast Cancer Res Treat. 2018;169:531-536.
Mango VL, Wynn RT, Feldman S, et al. Beyond wires and seeds: reflector-guided breast lesion localization and excision. Radiology. 2017;284:365-371.
Price ER, Khoury AL, Esserman LJ, Joe BN, Alvarado MD. Initial clinical experience with an inducible magnetic seed system for preoperative breast lesion localization. AJR Am J Roentgenol. 2018;210:913-917.
Cox CE, Garcia-Henriquez N, Glancy MJ, et al. Pilot study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions. Ann Surg Oncol. 2016;23:1824-1830.
Goudreau SH, Joseph JP, Seiler SJ. Preoperative radioactive seed localization for nonpalpable breast lesions: technique, pitfalls, and solutions. Radiographics. 2015;35:1319-1334.